Nivolumab-AVD reduces the risk of disease progression compared to brentuximab vedotin-AVD in advanced Hodgkin lymphoma
Nivolumab-AVD reduces the risk of disease progression compared to brentuximab vedotin-AVD in advanced Hodgkin lymphoma
Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients
Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer
Optimising cervical cancer care in Nigeria
Decision making in paediatric oncology
Achieving health equity in cancer care in the Philippines
Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients
Collective efforts to combat cancer in Cambodia
Adding new vaccine type to leading immunotherapy dramatically reduces melanoma recurrence
Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer